Product Categories
| Country: | China |
|---|---|
| Tel: | 0512-0512-51886999 |
| Mobile: | 17706251929 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Palmitoyl Tetrapeptide-7 | C34H62N8O7 | 221227-05-0 | Details |
| p-NCS-Bn-DOTA | C24H33N5O8S | 127985-74-4 | Details |
| DOTA-mono-NHStris(t-Buester) | C32H55N5O10 | 819869-77-7 | Details |
| pasireotide | C58H66N10O9 | 396091-73-9 | Details |
| Octreotide | C51H70N10O12S2 | 79517-01-4 | Details |
| Oligonucleotide Synthesis | C10H13N5O2 | 4097-22-7 | Details |
| 2'-F-iBu-dG-CE-Phosphoramidite; 2'-fluoro-N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine-3'-CE-Phosphoramidite | C44H53FN7O8P | 144089-97-4 | Details |
| Maleimido-mono-amide-DOTA | C22H34N6O9 | 1006711-90-5 | Details |
| Angiotensin II (1-4), human | C50H71N13O12 | 4474-91-3 | Details |
| Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH | C46H45N3O7 | 1572725-72-4 | Details |
| Oxytocin Acetate | C43H66N12O12S2 | 50-56-6 | Details |
| Eptifibatide | C35H49N11O9S2 | 188627-80-7 | Details |
| Peptide fluorescent modification | Details |
| Copper Peptide | C14H24N6O4 | 49557-75-7 | Details |
| Fmoc-Phe-Val-Gln(Trt)-Trp(Boc)-Leu-Ile-Ala-Gly | Details |
| c(RGDfK) | C27H41N9O7 | 161552-03-0 | Details |
| 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C45H56N7O9P | 150780-67-9 | Details |
| Fmoc-Asp(tBu)-Thr[PSI(Me,Me)Pro]-OH | C30H36N2O8 | 920519-32-0 | Details |
| Myristoyl Tetrapeptide-12 | C32H63N7O5 | 959610-24-3 | Details |
| Biotinoyl tripeptide-1 | C24H38N8O6S | 299157-54-3 | Details |
| 2'-F-Bz-dA-CE-Phosphoramidite; 2'-fluoro-N6-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine-3'-CE-Phosphoramidite | C47H51FN7O7P | 136834-22-5 | Details |
| Icatibant | C59H89N19O13S | 30308-48-4 | Details |
| Human GLP-1 (7-36)-NH2 | C149H226N40O45 | 107444-51-9 | Details |
| Fmoc-Ile-Ser[PSI(Me,Me)Pro]-OH | C27H32N2O6 | 1147996-34-6 | Details |
| GLP-1(7-37) | C151H228N40O47 | 106612-94-6 | Details |
| Peptide customization | Details |
| DOTA-tris(tBuester) | C28H52N4O8 | 137076-54-1 | Details |
| Nesiritide | C143H244N50O42S4 | 124584-08-3 | Details |
| BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Tyr(tBu)-Ser(tBu)-Ile-Aib-Leu | Details |
| White powder | CCaO3 | 471-34-1 | Details |
| CNV-38d(1-34) | C172H278N52O47S2 | 52232-67-4 | Details |
| Triptorelin Acetate | C64H82N18O13 | 57773-63-4 | Details |
| Tirzepatide | 2023788-19-2 | Details |
| Fmoc-Val-Thr[PSI(Me,Me)Pro]-OH | C27H32N2O6 | 168216-05-5 | Details |
| DOTA-NHS-ester | C22H33F9N5O12P | 1823122-52-6 | Details |
| Fmoc-Tyr(tBu)-Thr[PSI(Me,Me)Pro]-OH | C35H40N2O7 | 920519-31-9 | Details |
| Fmoc-Leu-Thr[PSI(Me,Me)Pro]-OH | C28H34N2O6 | 955048-89-2 | Details |
| Ziconotide acetate | C102H172N36O32S7 | 107452-89-1 | Details |
| 2'-F-Bz-dC-CE-Phosphoramidite; N4-benzoyl-5'-O-(4, 4'-dimethoxytrityl)-2'-fluoro-2'-deoxycytidine-3'-CE-Phosphoramidite | C46H51FN5O8P | 161442-19-9 | Details |
| Fmoc-Ile-Thr[PSI(Me,Me)Pro]-OH | C28H34N2O6 | 957780-52-8 | Details |
| Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH | C29H36N2O7 | 1425938-63-1 | Details |
| Fmoc-Tyr(tBu)-Ser[PSI(Me,Me)Pro]-OH | C34H38N2O7 | 878797-09-2 | Details |
| Fmoc-Trp(Boc)-Thr[PSI(Me,Me)Pro]-OH | C38H41N3O8 | 936707-21-0 | Details |
| Glucagon HCL | C6H9ClO5 | 11140-85-5 | Details |
| polypeptide | Details |
| Fmoc-Gly-Ser[PSI(Me,Me)Pro]-OH | C23H24N2O6 | 1095952-22-9 | Details |
| Fmoc-Phe-Ser[PSI(Me,Me)Pro]-OH | C30H30N2O6 | 878797-01-4 | Details |
| 2'-F-dU-CE-Phosphoramidite | Details |
| Acetyl Tetrapeptide-5 | C20H28N8O7 | 820959-17-9 | Details |
| Goserelin | C59H84N18O14 | 65807-02-5 | Details |
| Myristoyl Pentapeptide-17 | C41H81N9O6 | 959610-30-1 | Details |
| Morpholino T subunit; 6-(5-methyl-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-4-ritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate | C31H34ClN4O5P | 956139-30-3 | Details |
| Amyloid β-Protein(16-22) | C43H64N8O10 | 153247-41-7 | Details |
| Adrenomedullin (1-52), human | C264H406N80O77S3 | 148498-78-6 | Details |
| Pramlintide acetate | C173H273N51O56S2 | 196078-30-5 | Details |
| NOTA-bis(t-Buester) | C20H37N3O6 | 1161415-28-6 | Details |
| Fmoc-Asn(Trt)-Ser[PSI(Me,Me)Pro]-OH | C44H41N3O7 | 920519-33-1 | Details |
| Exenatide acetate | C186H286N50O62S | 141732-76-5 | Details |
| Palmitoyl Pentapeptide-4 | C39H75N7O10 | 214047-00-4 | Details |
| Morpholino U subunit | Details |
| Oligonucleotide customization | Details |
| BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly | Details |
| Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human | C184H273N51O57 | 99658-04-5 | Details |
| Fmoc-Ala-Ser[PSI(Me,Me)Pro]-OH | C24H26N2O6 | 252554-78-2 | Details |
| Angiotensin Converting Enzyme Inhibitor | C53H76N14O12 | 35115-60-7 | Details |
| Morpholino C subunit; 6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl Dimethylphosphoramidochloridate | C37H37ClN5O5P | 956139-21-2 | Details |
| Myristoyl-Hexapeptide-16 | C47H91N9O8 | 959610-54-9 | Details |
| Fmoc-Gln(Trt)-Ser[PSI(Me,Me)Pro]-OH | C45H43N3O7 | 1821378-64-6 | Details |
| DOTAGA-tetra(tBuester) | C35H64N4O10 | 306776-79-4 | Details |
| Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH | C27H32N2O6 | 339531-50-9 | Details |
| 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyluridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C40H49N4O9P | 110764-79-9 | Details |
| Ganirelix | C80H113ClN18O13 | 123246-29-7 | Details |
| Custom Peptide | Details |
| Fmoc-Phe-Thr[PSI(Me,Me)Pro]-OH | C31H32N2O6 | 1196703-48-6 | Details |
| Katacalcin | C97H154N34O36S2 | 85916-47-8 | Details |
| Glucagon | C153H225N43O49S | 16941-32-5 | Details |
| 4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- | C24H28F2N6O3 | 2471983-20-5 | Details |
| Leuprorelin | C61H88N16O14 | 74381-53-6 | Details |
| Acetyl tetrapeptide-3 | C22H39N9O5 | 827306-88-7 | Details |
| Morpholino A subunit; (6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl) methyl dimethylphosphoramidochloridate | C38H37ClN7O4P | 956139-18-7 | Details |
| GLP-2, human | C171H266N48O56S1 | 99120-49-7 | Details |
| Enfuvirtide | C204H301N51O64 | 159519-65-0 | Details |
| Fmoc-Ala-Thr[PSI(Me,Me)Pro]-OH | C25H28N2O6 | 252554-79-3 | Details |
| Peptide synthesis service | Details |
| DOTAM-mono-acid | C16H31N7O5 | 913528-04-8 | Details |
| Antide | C82H108ClN17O14 | 112568-12-4 | Details |
| Thymosin alpha 1 | C129H215N33O55 | 62304-98-7 | Details |
| Pal-Tripeptide-1 | C30H54N6O5 | 147732-56-7 | Details |
| Morpholino G subunit | Details |
| DOTAM-NHS-ester | C20H34N8O7 | 2236057-47-7 | Details |
| Fmoc-Asp(OtBu)-Lys(Boc)-Ile-Ala-Gln(Trt)-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-Ala | Details |
| 2'-OMe-Bz-C-CE-Phosphoramidite; N4-benzoyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-Cytidine-3'-CE-Phosphoramidite | C47H54N5O9P | 110764-78-8 | Details |
| Syn-AKE | C19H29N5O3.2(C2H4O2) | 823202-99-9 | Details |
| Leuprolide | C59H84N16O12 | 53714-56-0 | Details |
| Maleimido-mono-amide-NOTA | C18H27N5O7 | 1295584-83-6 | Details |
| H2N-Gly-Pro-Ser(tBu)-S(tBu)-Gly-Ala-Pro-Pro-Pro-S(tBu)-CONH2 | Details |
| 2'-O-Methyl-rA(N-Bz)phosphoramidite | C48H54N7O8P | 110782-31-5 | Details |
| Fmoc-Val-Ser[PSI(Me,Me)Pro]-OH | C26H30N2O6 | 186023-49-4 | Details |
| NOTAGA-tris(t-Buester) | 438553-50-3 | Details |
| (S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide | C29H36F2N6O5 | 2374782-82-6 | Details |
| Fmoc-Lys(Boc)-Ser[PSI(Me,Me)Pro]-OH | C32H41N3O8 | 957780-54-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | ||||